Clinical trial

Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart…

NCT00252187 · Horng Chen, Other · Completed

Key facts

NCT number NCT00252187
Title Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure
Official title Cardiac Hormone Replacement With BNP in Heart Failure: A Novel Therapeutic Strategy
Acronym SubqBNP
Lead sponsor Horng Chen, Other
Collaborators American Heart Association Scios, Inc. Industry National Heart, Lung, and Blood Institute (NHLBI) NIH National Center for Research Resources (NCRR)
Status Completed
Phase Phase 1/Phase 2
Study type Interventional
Conditions Congestive Heart Failure, Cardiomyopathy
Intervention type Drug, Other
Interventions B-type Natriuretic Peptide (BNP), Placebo
Enrollment 45
Start date Jan 1, 2000
Primary completion Jul 1, 2008
Completion Jun 1, 2010
First posted Nov 11, 2005
Last update posted Dec 20, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies